A fascinating discussion about advances in precision medicine and the impact on treatment options for patients with rare cancers. The webinar features TRACK Investigators Dr. Razelle Kurzrock, Dr. Vivek Subbiah, and Dr. Shumei Kato, and Molecular Tumor Board member Dr. Julia Elvin.
